Pancreatic Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with, or are suspected to have, a type of pancreatic cancer called pancreatic adenocarcinoma.
- People who are currently a patient at the University of Pennsylvania.
- People who are able to understand and agree to take part in the study (give informed consent).
- People who are 18 years of age or older.
Who may not be able to join:
- People who have a significant mental health condition, social circumstance, or other medical condition that, in the opinion of the study doctor, could increase health risks, make it difficult to follow the study requirements, or affect the ability to give informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Mark O'Hara, MD, Abramson Cancer Center, University of Pennsylvania
Phone: 267-455-9141
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To create a comprehensive system to collect, catalogue and store blood specimens from subjects with pancreatic cancer for future research use.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.